FilingSEC EDGAR20-F
Radiopharm Theranostics Files Annual Report and Discloses Business Updates
· SEC accepted
StageReporting
Filing content
The company filed its annual report, disclosing the impairment of previously acquired assets and updates on its collaboration and equity agreements with Lantheus.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…